Vorsitz: U. C. Hoppe (Köln), C. Tschöpe (Berlin)
| (V157) | Potential Protective Effects of Myeloid and Plasmacytoid Dendritic Cells (DCs) in the Myocardium in Dilated Cardiomyopathy |
| R. Pistulli, S. Drobnik, B. Brehm, W. Sommer, K. Schubert, D. Kretzschmar, G. Mall, H.-R. Figulla, A. Yilmaz (Jena) | |
| (V158) | Symmetric dimethylarginine (SDMA) predicts mortality in patients with chronic heart failure due to ischemic cardiomyopathy. |
| M. Anderssohn, M. Rosenberg, E. Schwedhelm, M. Lutz, N. Lüneburg, R. H. Böger, N. Frey (Hamburg, Kiel) | |
| (V159) | Leptin and Resistin plasma concentrations are associated with adverse outcome in chronic heart failure |
| P. Bobbert, A. Jenke, U. Kühl, U. Rauch-Kröhnert, H.-P. Schultheiss, C. Skurk (Berlin) | |
| (V160) | Prognostic impact of pulmonary function in systolic heart failure. |
| S. Brenner, G. Güder, D. Berliner, C. Morbach, B. Jany, R. Jahns, G. Ertl, S. Störk, C. E. Angermann (Würzburg) | |
| (V161) | Prevalence, correlates and prognostic impact of anaemia in systolic heart failure – a prospective cohort study |
| D. Berliner, S. Brenner, N. Deubner, G. Güder, S. Störk, G. Gelbrich, G. Ertl, C. E. Angermann (Würzburg, Leipzig) | |
| (V162) | Prognostic Impact of Sleep Duration and Sleep Efficiency on Mortality in Patients with Chronic Heart Failure |
| W. Hengstenberg, N. Plappert, C. Hengstenberg, G. Riegger, V. Novack, N. Maimon, M. Pfeifer, M. Arzt (Regensburg; Beer Sheva, IL) |